Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 5, 1999, Pages 423-433

  Beers, Michael F ^a,b   Atochina, Elena N ^a,b   Preston, Angela M ^a,b   Beck, James M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033134752     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90019-7     Document Type: Article

References (51)

1. 1. Martin WJ II. Pathogenesis of Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol 1993;8:356-7.
2. 2. Su TH, Martin WJ II. Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu Rev Med 1994;45:261-72.
3. 3. Walzer PD. Pathogenic mechanisms. In: Walzer PD, editor. Pneumocystis carinii pneumonia. 2nd ed. New York: Marcel Dekker; 1994. p. 251.
4. 4. Su TH, Natarajan V, Kachel DL, Moxley MA, Longmore WJ, Martin WJ II. Functional impairment of bronchoalveolar lavage phospholipids in early P. carinii pneumonia in rats. J Lab Clin Med 1996;127:263-71.
5. 5. Hoffman AGD, Lawrence M, Ognibene FP, Suffredeni AF, Lipschik GY, Kovacs JA, et al. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 1992;102:1730-6.
6. 6. Eijking EP, van Daal GJ, Tenbrinck R, Sluiters JF, Hannappel E, Erdmann W, et al. Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats. Intensive Care Medicine 1991;17:475-8.
7. 7. Marriage SC, Underhill H, Nadel S. Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia. Intensive Care Medicine 1996;22:611-2.
8. 8. Rose RM, Catalano PJ, Koziel H, Furlong ST. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am J Respir Crit Care Med 1994;149:332-8.
9. 9. Wiedmann HP. Surfactant and acquired lung diseases. J Lab Clin Med 1996; 127:239-41.
10. 10. Slater AJ, Nichani SH, Macrae D, Wilkinson KA, Novelli V, Tasker RC. Surfactant adjuvant therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukemia. Intensive Care Medicine 1995;21:261-3.
11. 11. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-67.
12. 12. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 1998;275:L1-13.
13. 13. McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoproteinof P. carinii. Biochemistry 1997;36:8092-9.
14. 14. O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH. Surfactant protein D interacts with P. carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 1995;6:2699-710.
15. 15. Emrie PA, Shannon JM, Mason RJ, Fisher JH. cDNA and deduced amino acid sequence for the rat hydrophobic pulmonary surfactant-associated protein, SP-B. Biochim Biophys Acta 1989;994:215-21.
16. 16 Robertson B, Kobayashi T, Ganzuka, Grossmann G, Li WZ, Suzuki Y. Experimental neonatal respiratory failure induced by a monoclonal antibody to hydrophobic surfactant-associated protein SP-B. Pediatr Res 1991;30:239-43.
17. 17. Kobayashi T, Robertson B, Grossman G, Nitta K, Curstedt T, Suzuki Y. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant associated hydrophobic protein SP-B. Acta Paedriatr 1992;81:665-71.
18. 18. Gregory TJ, Longmore WJ, Moxley MA, Whitsell JA, Reed CR, Fowler AD, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81.
19. 19. Nogee LM, deMello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-10.
20. 20. Ballard PL, Nogee LM, Beers MF, Ballard R, Planer BC, Polk L, et al. Partial deficiency of surfactant protein B in a compound heterozygote with a new mutation. Pediatrics 1995;96:1046-52.
21. 21. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, et al. Targetted disruption of the SP-B gene results in alteration of surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92:7794-8.
22. 22. Clark JC, Weaver TE, Iwamoto HS, Ikegami M, Jobe AH, Hull WM, et al. Decreased lung compliance and air trapping in heterozygous SP-B deficient mice. Am J Respir Cell Mol Biol 1997;16:46-52.
23. 23. Phelps DS, Rose RM. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am Rev Respir Dis 1991;143:1072-5.
24. 24. Phelps DS, Umstead TM, Rose RM, Fishman JA. Surfactant protein A levels increase during Pneumocystis carinii pneumonia in the rat. Eur Respir J 1996;9:565-70.
25. 25. Sternberg RI, Whitsett JA, Hill WM, Baughman RP. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J Lab Clin Med 1995;125:462-9.
26. 26. Rice WR, Singleton FM, Links MJ, Walzer PD. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J Clin Invest 1993;92:2778-82.
27. 27. Lipschik GY, Moore SD, Treml JF, Beers MF. Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by alveolar type II cells. J Infect Dis 1998;177:182-7.
28. 28. Beck JM, Liggit HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma Interferon. Infect Immun 1991;59:3859-62.
29. 29. Beck JM, Newbury RL, Palmer BE. Pneumocystis carinii pneumonia in seid mice induced by viable organisms propagated in vitro. Infect Immun 1996;64:4643-7.
30. 30. Beck JM, Newbury RL, Palmer BE, Warnoel MI., Byrd PK, Kaltreider HB. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice. J Lab Clin Med 1996;128:477-87.
31. 31. Shellito J, Suzara VV, Blumenfeld W, Beck JM, Sieger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686-93.
32. 32. Harmsen AG, Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990;172:937-45.
33. 33. Young SL, Silbajoris R. Dexamethasone increases adult rat surfactant lipids. J Appl Physiol 1986;60:1665-72.
34. 34. Wali A, Beers MF, Dodia C, Feinstein SI, Fisher AB. ATP and cAMP stimulate the synthesis of surfactant protein SP-A in rat lung. Am J Physiol 1993;264:L431-7.
35. 35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;161:156-9.
36. 36. Beers MF, Kim CY, Dodia C, Fisher AB. Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies. J Biol Chem 1994;269:20318-28.
37. 37. Kramer HJ, Schmidt R, Gunther A, Becker G, Suzuki Y, Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1995;152:1540-4.
38. 38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976;72:248-54.
39. 39. Beers MF, Bates SR, Fisher AB. Differential extraction for the rapid purification of bovine surfactant protein B. Am J Physiol 1992;262:L773-8.
40. 40. Ausbel FM, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. New York: John Wiley and Sons; 1995.
41. 41. Barbu V, Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res 1989;17:7115.
42. 42. Beers MF, Shuman H, Liley HG, Floros J, Gonzales LW, Yue N, et al. Surfactant protein B in human fetal lung: developmental regulation and glucocorticoid regulation. Pediatr Res 1995;38:668-75.
43. 43. Collaborative Group on Antenatal Steroids. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynceol 1981;141:276.
44. 44. Yoneda K, Walzer PD. Attachment of Pneumocystis carinii to type I alveolar cells studied by freeze-fracture electron microscopy. Infect Immun 1983;40:812-5.
45. 45. Millard PR, Wakefield AE, Hopkins JM. A sequential ultrastruclural study of rat lungs infected with Pneumocystis carinii to investigate the appearance of organism, its relationships, and its effects on pneumocytes. Int J Exp Pathol 1990;71:895-904.
46. 46. Long EG, Smith JS, Meier JL. Attachment of Pneumocystis carinii to rat pneumocytes. Lab Invest 1986;54:609-15.
47. 47. Pottratz S, Weir AL. Attachment of Pneumocystis carinii to primary cultures of rat alveolar epithelial cells. Exp Cell Res 1995;221:357-62.
48. 48. Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279-84.
49. 49. Kolls JK, Beck JM, Nelson S, Summer WR, Shellito J, Alveolar maerophage release of tumor necrosis factor α during murine Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol 1993;8:370-6.
50. 50. Pryhuber GS, Bachurski C, Hirsch R, Bacon A, Whitsett JA. Tumor necrosis factor-α decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996;270:L714-21.
51. 51. Bachurski CJ, Pryhuber GS, Glasser SW, Kelly SF, Whitsett JA. Tumor necrosis factor-α inhibits surfactant protein C gene transcription. J Biol Chem 1995;270:19402-7.